InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by Winter Suzanne C, Chief Executive Officer. Officer active across 1 companies, notably ACCURAY INC. In total, 10 disclosures have been published. Total volume traded: €342k. The latest transaction was filed on 31 January 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations10 total
€2,409761 shares@ €3.16521.4% of flow
Common Stock
SEC:0001214659-22-001959·
Ideal exit: 28 Oct 2022 (T+270)
€2,409761 shares@ €3.16520.0075% mcap0.7% of flow
Common Stock
SEC:0001214659-22-001959:0·
Ideal exit: 28 Oct 2022 (T+270)
€35,57411,239 shares@ €3.165220.8% of flow
Common Stock
SEC:0001214659-22-001659·
Ideal exit: 28 Oct 2022 (T+270)
€35,57411,239 shares@ €3.16520.11% mcap10.4% of flow
Common Stock
SEC:0001214659-22-001659:0·
Ideal exit: 28 Oct 2022 (T+270)
€27,3796,748 shares@ €4.057416.0% of flow
Common Stock
SEC:0001214659-21-012673·
€27,3796,748 shares@ €4.05740.085% mcap8.0% of flow
Common Stock
SEC:0001214659-21-012673:0·
€105,68623,440 shares@ €4.508861.8% of flow
Common Stock
SEC:0001214659-21-011153·
€105,68623,440 shares@ €4.50880.33% mcap30.9% of flow
Common Stock
SEC:0001214659-21-011153:0·
0126,582 shares0
Common Stock
SEC:0001214659-21-010193·
0126,582 shares0
Common Stock
SEC:0001214659-21-010193:0·
10 of 10 declarations
About Winter Suzanne C
Suzanne C. Winter is the Chief Executive Officer of Accuray Inc. She oversees the company's operations and strategy, ensuring that Accuray remains at the forefront of innovation in the medical technology sector.
